John Bolla Promoted to COO, a Newly Created Position at Lantheus Holdings

John Bolla Spent 20 Years at GlaxoSmithKline plc, a Global Branded Pharmaceutical Company

As Chief Operations Officer, John Bolla will lead Lantheus Technical Operations, Engineering & Facilities, Environment, Health & Safety, Human Resources, and Information Technology organizations in addition to his oversight of the Puerto Rico business unit.

“I am very pleased to announce John’s appointment to the newly created role of Chief Operations Officer,” said Ms. Heino. “Since joining Lantheus last May, he has demonstrated significant operational and cross-functional leadership. As we drive strategic change within the Company to better position us for growth, John is ideally suited to contribute in his new role.”

“I appreciate the confidence that Lantheus has shown in me and I’m excited to take on this new role,” said Bolla. “I look forward to the opportunity to participate in the growth of the Company as we drive operational excellence at this important time in our evolution.”

Prior to joining Lantheus in May 2018, John Bolla spent 20 years at GlaxoSmithKline plc (GSK), a global branded pharmaceutical company. He held various senior leadership roles at GSK, including Vice President, Supply Chain, North America, where he was responsible for leading all manufacturing, supply planning, logistics and distribution for GSK’s largest global market. He also held senior roles as Vice President and Site General Manager for a large GSK manufacturing facility in the U.S., as well as Vice President and Global Head of External Supply and Global Contract Manufacturing. He has also served in multiple senior procurement leadership roles at GSK. He holds a Bachelor of Science in Business Administration/Accounting from The University of Central Florida.

Other promotion here.

WE WELCOME YOUR VIEWS

Please enter your comment!
Please enter your name here